Clinical Trials in Spontaneous Intracerebral Hemorrhage

Fred Rincon, Stephan A. Mayer

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Spontaneous intracerebral hemorrhage (ICH) is by far the most destructive form of stroke1. Morbidity and mortality have not substantially changed over the last 30years and current treatment options lag behind those for ischemic stroke and subarachnoid hemorrhage1. Apart from the management in a specialized stroke or neurological intensive care unit, no specific therapies have been shown to consistently improve outcomes after ICH2. As the most common etiology of ICH is hypertension3.this places a large proportion of the population at risk.

Original languageEnglish
Title of host publicationHandbook of Neuroemergency Clinical Trials
PublisherElsevier
Pages47-64
Number of pages18
ISBN (Electronic)9780128040645
ISBN (Print)9780128041017
DOIs
StatePublished - 1 Jan 2017

Keywords

  • ATACH
  • Cerebral blood flow
  • MISTIE
  • Neuroprotection
  • STICH
  • Systolic blood pressure

Fingerprint

Dive into the research topics of 'Clinical Trials in Spontaneous Intracerebral Hemorrhage'. Together they form a unique fingerprint.

Cite this